BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect 2018;77:368-78. [PMID: 29964140 DOI: 10.1016/j.jinf.2018.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Vorobieva S Jensen V, Furberg AS, Slotved HC, Bazhukova T, Haldorsen B, Caugant DA, Sundsfjord A, Valentiner-Branth P, Simonsen GS. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines. BMC Infect Dis 2020;20:279. [PMID: 32293324 DOI: 10.1186/s12879-020-04998-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Jullien S, Sharma R, Lhamu Mynak M, Henares D, Muñoz-Almagro C, Bassat Q. Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection. BMC Infect Dis 2020;20:940. [PMID: 33297987 DOI: 10.1186/s12879-020-05674-4] [Reference Citation Analysis]
3 Reslan L, Finianos M, Bitar I, Moumneh MB, Araj GF, Zaghlout A, Boutros C, Jisr T, Nabulsi M, Kara Yaccoub G, Hamze M, Osman M, Bou Raad E, Hrabak J, Matar GM, Dbaibo G. The Emergence of Invasive Streptococcus pneumoniae Serotype 24F in Lebanon: Complete Genome Sequencing Reveals High Virulence and Antimicrobial Resistance Characteristics. Front Microbiol 2021;12:637813. [PMID: 33746930 DOI: 10.3389/fmicb.2021.637813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Benadji A, Duval X, Danis K, Hoen B, Page B, Béraud G, Vernet-Garnier V, Strady C, Brieu N, Maulin L, Roy C, Ploy MC, Gaillat J, Varon E, Tubiana S; COMBAT Study Group., SIIP Study Group. Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease. Infection 2021. [PMID: 34468953 DOI: 10.1007/s15010-021-01688-5] [Reference Citation Analysis]
5 Janssens E, Flamaing J, Vandermeulen C, Peetermans WE, Desmet S, De Munter P. The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value. Acta Clin Belg 2022;:1-9. [PMID: 35171752 DOI: 10.1080/17843286.2022.2039865] [Reference Citation Analysis]
6 Corcoran M, Mereckiene J, Cotter S, Murchan S, Cunney R, Humphreys H. Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018. Pediatr Infect Dis J 2020;39:339-44. [PMID: 31815827 DOI: 10.1097/INF.0000000000002549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Gagetti P, Lo SW, Hawkins PA, Gladstone RA, Regueira M, Faccone D, Sireva-Argentina Group, Klugman KP, Breiman RF, McGee L, Bentley SD, Corso A. Population genetic structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in children in Argentina. Microb Genom 2021;7. [PMID: 34586054 DOI: 10.1099/mgen.0.000636] [Reference Citation Analysis]
8 Hjálmarsdóttir MÁ, Haraldsson G, Quirk SJ, Haraldsson Á, Erlendsdóttir H, Kristinsson KG. Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland. PLoS One 2020;15:e0230332. [PMID: 32182260 DOI: 10.1371/journal.pone.0230332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lapidot R, Faits T, Ismail A, Allam M, Khumalo Z, Macleod W, Kwenda G, Mupila Z, Nakazwe R, Segrè D, Johnson WE, Thea DM, Mwananyanda L, Gill CJ. Nasopharyngeal Dysbiosis Precedes the Development of Lower Respiratory Tract Infections in Young Infants, a Longitudinal Infant Cohort Study. Gates Open Res 2022;6:48. [DOI: 10.12688/gatesopenres.13561.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Desmet S, Wouters I, Heirstraeten LV, Beutels P, Van Damme P, Malhotra-Kumar S, Maes P, Verhaegen J, Peetermans WE, Lagrou K, Theeten H. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease. Vaccine 2021;39:372-9. [PMID: 33308889 DOI: 10.1016/j.vaccine.2020.11.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bedeley E, Gori A, Yeboah-Manu D, Diallo K. Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae. Front Microbiol 2021;12:658824. [PMID: 33967998 DOI: 10.3389/fmicb.2021.658824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Cao H, Chiu KH, Chiu SS, Jiang S, Chow KH, Ho PL. Genomic investigation of a Streptococcus pneumoniae serotype 24F strain causing meningoencephalitis in Hong Kong. Int J Med Microbiol 2021;311:151543. [PMID: 34864352 DOI: 10.1016/j.ijmm.2021.151543] [Reference Citation Analysis]
13 Henares D, Brotons P, de Sevilla MF, Fernandez-Lopez A, Hernandez-Bou S, Perez-Argüello A, Mira A, Muñoz-Almagro C, Cabrera-Rubio R. Differential nasopharyngeal microbiota composition in children according to respiratory health status. Microb Genom 2021;7. [PMID: 34699345 DOI: 10.1099/mgen.0.000661] [Reference Citation Analysis]
14 Hu T, Weiss T, Bencina G, Owusu-Edusei K, Petigara T. Comprehensive value assessments for new pediatric pneumococcal conjugate vaccines. J Med Econ 2021;24:1083-6. [PMID: 34433365 DOI: 10.1080/13696998.2021.1970974] [Reference Citation Analysis]
15 Wyllie AL, Warren JL, Regev-Yochay G, Givon-Lavi N, Dagan R, Weinberger DM. Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children. Clin Infect Dis 2021;72:e768-75. [PMID: 32989457 DOI: 10.1093/cid/ciaa1480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Junges R, Maienschein-Cline M, Morrison DA, Petersen FC. Complete Genome Sequence of Streptococcus pneumoniae Serotype 19F Strain EF3030. Microbiol Resour Announc 2019;8:e00198-19. [PMID: 31072896 DOI: 10.1128/MRA.00198-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Chan J, Nguyen CD, Dunne EM, Kim Mulholland E, Mungun T, Pomat WS, Rafai E, Satzke C, Weinberger DM, Russell FM. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine 2019;37:6299-309. [PMID: 31500968 DOI: 10.1016/j.vaccine.2019.08.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 Britton KJ, Pickering JL, Pomat WS, de Gier C, Nation ML, Pell CL, Granland CM, Solomon V, Ford RL, Greenhill A, Hinds J, Moore HC, Richmond PC, Blyth CC, Lehmann D, Satzke C, Kirkham LS; 10v13vPCV trial team. Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants. Vaccine 2021;39:5401-9. [PMID: 34384633 DOI: 10.1016/j.vaccine.2021.07.085] [Reference Citation Analysis]
19 Bentley SD, Lo SW. Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics. Genome Med 2021;13:84. [PMID: 34001237 DOI: 10.1186/s13073-021-00901-2] [Reference Citation Analysis]
20 Nakano S, Fujisawa T, Ito Y, Chang B, Matsumura Y, Yamamoto M, Suga S, Ohnishi M, Nagao M. Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017. Emerg Infect Dis 2020;26:2660-8. [PMID: 33079039 DOI: 10.3201/eid2611.200087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Steens A, Knol MJ, Freudenburg-de Graaf W, de Melker HE, van der Ende A, van Sorge NM. Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands. Microorganisms 2022;10:972. [DOI: 10.3390/microorganisms10050972] [Reference Citation Analysis]
22 Amin-Chowdhury Z, Groves N, Sheppard CL, Litt D, Fry NK, Andrews N, Ladhani SN. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes. Vaccine 2021;39:1997-2004. [PMID: 33715901 DOI: 10.1016/j.vaccine.2021.02.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Uddén F, Rünow E, Slotved HC, Fuursted K, Ahl J, Riesbeck K. Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13. J Infect 2021;83:190-6. [PMID: 34062179 DOI: 10.1016/j.jinf.2021.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 van der Linden M, Imöhl M, Perniciaro S. Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS One 2019;14:e0220453. [PMID: 31369597 DOI: 10.1371/journal.pone.0220453] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
25 Massora S, Lessa FC, Moiane B, Pimenta FC, Mucavele H, Chaúque A, Cossa A, Verani JR, Tembe N, da Gloria Carvalho M, Muñoz-Almagro C, Sigaúque B. Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique. Vaccine 2019;37:7470-7. [PMID: 31575493 DOI: 10.1016/j.vaccine.2019.09.079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA, Gladstone RA, McGee L, Breiman RF, Bentley SD, Klugman KP, Lo SW, Ravikumar KL. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Microb Genom 2021;7. [PMID: 34494953 DOI: 10.1099/mgen.0.000645] [Reference Citation Analysis]
27 Hu T, Weiss T, Owusu-Edusei K, Petigara T. Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States. J Med Econ 2020;23:1653-60. [PMID: 33084447 DOI: 10.1080/13696998.2020.1840216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hu T, Weiss T, Bencina G, Owusu-Edusei K, Petigara T. Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries. J Med Econ 2021;24:1098-107. [PMID: 34461796 DOI: 10.1080/13696998.2021.1970975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Càmara J, Ardanuy C. Pneumococcal disease and conjugate vaccines. Enferm Infecc Microbiol Clin (Engl Ed) 2018;36:605-6. [PMID: 30220517 DOI: 10.1016/j.eimc.2018.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Cook HM, Giele CM, Jayasinghe SH, Wakefield A, Krause VL; Enhanced Invasive Pneumococcal Disease Surveillance Working Group. An outbreak of serotype-1 sequence type 306 invasive pneumococcal disease in an Australian Indigenous population. Commun Dis Intell (2018) 2020;44. [PMID: 32988336 DOI: 10.33321/cdi.2020.44.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Wang Q, Shi W, Li Y, Gao W, Yuan L, Dong F, Yao K. Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019). Vaccine 2020;38:7858-64. [PMID: 33164807 DOI: 10.1016/j.vaccine.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Cohen R, Levy C, Ouldali N, Goldrey M, Béchet S, Bonacorsi S, Varon E. Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation. Clin Infect Dis 2021;72:1453-6. [PMID: 32804200 DOI: 10.1093/cid/ciaa917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Betts M, Jarvis S, Jeffries A, Gori A, Chaguza C, Msefula J, Weight CM, Kwambana-Adams B, French N, Swarthout TD, Brown JS, Heyderman RS. Complete Genome Sequence of Streptococcus pneumoniae Strain BVJ1JL, a Serotype 1 Carriage Isolate from Malawi. Microbiol Resour Announc 2021;10:e0071521. [PMID: 34591678 DOI: 10.1128/MRA.00715-21] [Reference Citation Analysis]
34 Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother 2021;:1-10. [PMID: 34726580 DOI: 10.1080/21645515.2021.1985353] [Reference Citation Analysis]
35 Wouters I, Desmet S, Van Heirstraeten L, Blaizot S, Verhaegen J, Van Damme P, Malhotra-Kumar S, Theeten H; NPcarriage Study Group. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium. Vaccine 2019;37:1080-6. [PMID: 30665775 DOI: 10.1016/j.vaccine.2018.12.068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
36 Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M. Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain. Front Microbiol 2020;11:309. [PMID: 32174903 DOI: 10.3389/fmicb.2020.00309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
37 Turner P, Leab P, Ly S, Sao S, Miliya T, Heffelfinger JD, Batmunkh N, Lessa FC, Walldorf JA, Hyde TB, Ork V, Hossain MS, Gould KA, Hinds J, Cooper BS, Ngoun C, Turner C, Day NPJ. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children. Clin Infect Dis 2020;70:1580-8. [PMID: 31175819 DOI: 10.1093/cid/ciz481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
38 Levy C, Varon E, Ouldali N, Béchet S, Bonacorsi S, Cohen R. Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation. Clinical Infectious Diseases 2019. [DOI: 10.1093/cid/ciz221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
39 Sim JY, Chang LY, Chang TH, Chen JM, Lee PI, Huang LM, Lu CY. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan. J Formos Med Assoc 2020;119:1608-18. [PMID: 32747171 DOI: 10.1016/j.jfma.2020.07.026] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, Givon-Lavi N, Hawkins PA, Cornick JE, Kwambana-Adams B, Law PY, Ho PL, Antonio M, Everett DB, Dagan R, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD; Global Pneumococcal Sequencing Consortium. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 2019;19:759-69. [PMID: 31196809 DOI: 10.1016/S1473-3099(19)30297-X] [Cited by in Crossref: 64] [Cited by in F6Publishing: 24] [Article Influence: 21.3] [Reference Citation Analysis]
41 Sanz Moreno JC, Ramos Blázquez B. Papel del estado de portador en el control de enfermedades infecciosas y su relación con la vacunación. REMASP 2019;2:1-8. [DOI: 10.36300/remasp.2019.020] [Reference Citation Analysis]
42 Kawabata T, Tenokuchi Y, Yamakuchi H, Sameshima H, Katayama H, Ota T, Tokunaga M, Takezaki T, Tamae S, Nakamura T, Chang B, Kodama Y, Imuta N, Ooka T, Okamoto Y, Suga S, Nishi J. Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential. Pediatr Infect Dis J 2020;39:85-7. [PMID: 31815842 DOI: 10.1097/INF.0000000000002508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Müller A, Salmen A, Aebi S, de Gouveia L, von Gottberg A, Hathaway LJ. Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid. BMC Microbiol 2020;20:16. [PMID: 31959125 DOI: 10.1186/s12866-020-1700-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Uddén F, Filipe M, Slotved HC, Yamba-Yamba L, Fuursted K, Pintar Kuatoko P, Larsson M, Bjurgert J, Månsson V, Pelkonen T, Reimer Å, Riesbeck K. Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine. Vaccine 2020;38:7928-37. [PMID: 33143954 DOI: 10.1016/j.vaccine.2020.10.060] [Reference Citation Analysis]
45 Levy C, Ouldali N, Caeymaex L, Angoulvant F, Varon E, Cohen R. Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe. The Journal of Pediatrics 2019;213:252-253.e3. [DOI: 10.1016/j.jpeds.2019.07.057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
46 Müller A, Kleynhans J, de Gouveia L, Meiring S, Cohen C, Hathaway LJ, von Gottberg A; for GERMS-SA. Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018. Emerg Infect Dis 2022;28:166-79. [PMID: 34932448 DOI: 10.3201/eid2801.210956] [Reference Citation Analysis]
47 Brandileone MDC, Zanella RC, Almeida SC, Cassiolato AP, Lemos APSD, Salgado MM, Higa FT, Minamisava R, Andrade AL. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine 2019;37:5357-63. [DOI: 10.1016/j.vaccine.2019.07.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
48 Severance R, Schwartz H, Dagan R, Connor L, Li J, Pedley A, Hartzel J, Sterling TM, Nolan KM, Tamms GM, Musey LK, Buchwald UK. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU). Hum Vaccin Immunother 2021;:1-14. [PMID: 34726574 DOI: 10.1080/21645515.2021.1976581] [Reference Citation Analysis]
49 Simon JK, Staerke NB, Hemming-Harlo M, Layle S, Dagan R, Shekar T, Pedley A, Jumes P, Tamms G, Sterling T, Musey L, Buchwald UK; V114-020 PNEU-TRUE study group. Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE). Vaccine 2022:S0264-410X(21)01675-3. [PMID: 35039194 DOI: 10.1016/j.vaccine.2021.12.067] [Reference Citation Analysis]
50 El-Kholy A, Badawy M, Gad M, Soliman M. Serotypes and Antimicrobial Susceptibility of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children Less Than 5 Years Old in Egypt. Infect Drug Resist 2020;13:3669-77. [PMID: 33116686 DOI: 10.2147/IDR.S250315] [Reference Citation Analysis]
51 Malik TM, Mohammed-Awel J, Gumel AB, Elbasha EH. Mathematical assessment of the impact of cohort vaccination on pneumococcal carriage and serotype replacement. J Biol Dyn 2021;15:S214-47. [PMID: 33594952 DOI: 10.1080/17513758.2021.1884760] [Reference Citation Analysis]
52 Song JY, Chang CJ, Andrews C, Diez-Domingo J, Oh MD, Dagan R, Hartzel J, Pedley A, Li J, Sterling T, Tamms G, Chiarappa JA, Lutkiewicz J, Musey L, Tu Y, Buchwald UK; V114-016 (PNEU-PATH) study group. Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH). Vaccine 2021;39:6422-36. [PMID: 34489128 DOI: 10.1016/j.vaccine.2021.08.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Winje BA, Vestrheim DF, White RA, Steens A. The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children. Microorganisms 2021;9:1774. [PMID: 34442853 DOI: 10.3390/microorganisms9081774] [Reference Citation Analysis]
54 Ouldali N, Cohen R, Levy C, Gelbert-Baudino N, Seror E, Corrard F, Vie Le Sage F, Michot AS, Romain O, Bechet S, Bonacorsi S, Angoulvant F, Varon E. Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment. J Antimicrob Chemother 2019;74:3077-86. [PMID: 31280295 DOI: 10.1093/jac/dkz281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
55 Severiche-Bueno DF, Severiche-Bueno DF, Bastidas A, Caceres EL, Silva E, Lozada J, Gomez S, Vargas H, Viasus D, Reyes LF. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia. Int J Infect Dis 2021;105:32-9. [PMID: 33582374 DOI: 10.1016/j.ijid.2021.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ouldali N, Varon E, Levy C, Angoulvant F, Georges S, Ploy MC, Kempf M, Cremniter J, Cohen R, Bruhl DL, Danis K. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. Lancet Infect Dis 2021;21:137-47. [PMID: 32702302 DOI: 10.1016/S1473-3099(20)30165-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
57 Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M, Diaz-Conradi A, Marti C, Motje M, Galles C, Morta M, Izquierdo C, Moraga-Llop F, Campins M, Salleras L, Jane M, Dominguez A, Garcia-Garcia JJ, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One 2020;15:e0228612. [PMID: 32027715 DOI: 10.1371/journal.pone.0228612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
58 Chaguza C, Yang M, Jacques LC, Bentley SD, Kadioglu A. Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms. Trends in Microbiology 2021. [DOI: 10.1016/j.tim.2021.11.007] [Reference Citation Analysis]
59 Wasserman MD, Perdrizet J, Grant L, Hayford K, Singh S, Saharia P, Horn EK, Farkouh RA. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infect Dis Ther 2021;10:2701-20. [PMID: 34633639 DOI: 10.1007/s40121-021-00544-1] [Reference Citation Analysis]